Heron Therapeutics Ownership | Who Owns Heron Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Heron Therapeutics Ownership Summary


Heron Therapeutics is owned by 85.35% institutional investors, 0.74% insiders, and 13.91% retail investors. Rubric capital management lp is the largest institutional shareholder, holding 17.40% of HRTX shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.07% of its assets in Heron Therapeutics shares.

HRTX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockHeron Therapeutics85.35%0.74%13.91%
SectorHealthcare Stocks 492.67%11.09%-403.76%
IndustryBiotech Stocks 295.31%11.22%-206.53%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Rubric capital management lp26.71M17.40%$58.77M
Blackrock funding, inc. /de9.99M6.48%$12.58M
Blackrock8.33M5.51%$29.14M
Vanguard group8.46M5.49%$10.66M
Adage capital partners gp7.85M5.10%$16.25M
Velan capital investment management lp6.99M4.55%$15.37M
Palisade capital management, lp5.09M3.30%$10.53M
Tejara capital4.59M2.98%$5.78M
D. e. shaw3.72M2.44%$5.70M
Geode capital management3.64M2.37%$4.59M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Velan capital investment management lp6.99M15.81%$15.37M
Tejara capital4.59M3.02%$5.78M
Jw asset management3.29M1.99%$4.15M
Congress park capital2.89M1.13%$3.64M
Rubric capital management lp26.71M1.05%$58.77M
Stonepine capital management850.10K0.87%$1.07M
Cm management750.00K0.79%$945.00M
Orchard capital management677.29K0.74%$853.38K
Richmond brothers572.12K0.46%$720.87K
Palisade capital management, lp5.09M0.30%$10.53M

Top Buyers

HolderShares% AssetsChange
Citigroup2.48M0.00%2.42M
Millennium management1.40M0.00%1.18M
Blackrock8.33M0.00%1.04M
Jw asset management3.29M1.99%954.89K
New york state common retirement fund2.58M0.00%816.67K

Top Sellers

HolderShares% AssetsChange
Orbimed advisors---6.51M
Point72 asset management---4.78M
Aigh capital management---3.01M
Marshall wace, llp1.31M0.00%-1.59M
Goldman sachs group655.16K0.00%-1.05M

New Positions

HolderShares% AssetsChangeValue
Pale fire capital se471.19K0.07%471.19K$593.70K
Bridgeway capital management300.00K0.01%300.00K$459.00K
Walleye capital299.79K0.00%299.79K$620.57K
Qube research132.78K0.00%132.78K$274.86K
Creative planning98.45K0.00%98.45K$216.59K

Sold Out

HolderChange
Allspring global investments-1.00
Toronto dominion bank-9.00
Lindbrook capital-16.00
Mid-american wealth advisory group-24.00
Ifp advisors-35.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20251742.35%131,460,8435.36%851.29%8714.47%34-26.09%
Mar 31, 20257-95.81%36,006,112-68.67%230.41%4-94.12%--100.00%
Dec 31, 202490-48.86%38,837,514-68.12%250.40%37-57.95%24-36.84%
Sep 30, 2024175-9.79%121,805,039-6.02%791.08%87-23.01%38-2.56%
Jun 30, 202419417.58%129,609,4628.61%851.36%11359.15%39-17.02%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF4.68M3.07%-
Vanguard Total Stock Mkt Idx Inv4.58M2.99%-101.04K
iShares Russell 2000 ETF3.74M2.44%-
Palisade Small Cap Core Equity3.19M2.09%-141.42K
Biotech Growth Ord2.58M1.70%2.58M
Franklin US Small Cap Growth Equity1.80M1.19%-
Vanguard Institutional Extnd Mkt Idx Tr1.55M1.01%-674.04K
Fidelity Small Cap Index1.54M1.00%339.16K
iShares Russell 2000 Value ETF1.18M0.77%-
State St Russell Sm/Mid Cp® Indx NL Cl C851.80K0.56%3.84K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 08, 2025Rubric Capital Management LP-Buy$3.58M
Aug 08, 2025Rubric Capital Management LP-Buy-
Aug 08, 2025Rubric Capital Management LP-Buy-
Aug 08, 2025Morgan Adam-Buy$105.02K
Aug 08, 2025Morgan Adam-Buy$2.65M

Insider Transactions Trends


DateBuySell
2025 Q4--
2025 Q35-
2025 Q2--
2025 Q1--
2024 Q4--

HRTX Ownership FAQ


Who Owns Heron Therapeutics?

Heron Therapeutics shareholders are primarily institutional investors at 85.35%, followed by 0.74% insiders and 13.91% retail investors. The average institutional ownership in Heron Therapeutics's industry, Biotech Stocks , is 295.31%, which Heron Therapeutics falls below.

Who owns the most shares of Heron Therapeutics?

Heron Therapeutics’s largest shareholders are Rubric capital management lp (26.71M shares, 17.40%), Blackrock funding, inc. /de (9.99M shares, 6.48%), and Blackrock (8.33M shares, 5.51%). Together, they hold 29.39% of Heron Therapeutics’s total shares outstanding.

Does Blackrock own Heron Therapeutics?

Yes, BlackRock owns 5.51% of Heron Therapeutics, totaling 8.33M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 29.14M$. In the last quarter, BlackRock increased its holdings by 1.04M shares, a 14.27% change.

Who is Heron Therapeutics’s biggest shareholder by percentage of total assets invested?

Velan capital investment management lp is Heron Therapeutics’s biggest shareholder by percentage of total assets invested, with 15.81% of its assets in 6.99M Heron Therapeutics shares, valued at 15.37M$.

Who is the top mutual fund holder of Heron Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Heron Therapeutics shares, with 3.07% of its total shares outstanding invested in 4.68M Heron Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools